- Is Cure LBSL a tax-exempt 501(c)(3)?
- Yes. Cure LBSL is recognised by the IRS as a 501(c)(3) organisation (EIN 46-2829156). The IRS recognised Cure LBSL as tax-exempt in December 2013.
- What is Cure LBSL's EIN?
- Cure LBSL's Employer Identification Number (EIN) is 46-2829156. The EIN was assigned by the IRS in December 2013. Donors and grantmakers use the EIN to verify tax-exempt status with the IRS.
- What does Cure LBSL do?
- Provide funding to rare disease research and support affected families
- Where is Cure LBSL located?
- Cure LBSL is located at 3520 S Wakefield St, Arlington, VA, 22206.
- When was Cure LBSL founded or recognised by the IRS?
- Cure LBSL was recognised by the IRS as a tax-exempt organisation in December 2013. The IRS ruling date is the earliest authoritative date available for most US nonprofits.
- What is Cure LBSL's annual revenue?
- On its most recent Form 990 (fiscal year 2025), Cure LBSL reported $652K in total revenue and $307K in total expenses.
- Has Cure LBSL been auto-revoked by the IRS?
- No. Cure LBSL (EIN 46-2829156) does not appear on the IRS Auto-Revocation List. Givalgo Discover cross-references the IRS Auto-Revocation List on every profile load; if status changes, this page reflects it.
- Is Cure LBSL listed in IRS Publication 78?
- Yes. Cure LBSL is listed in IRS Publication 78 as an organisation eligible to receive tax-deductible charitable contributions. Pub 78 status is the canonical IRS signal that donations to an org are deductible.
